Liberty Mutual Group Asset Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,671
Closed -$1.11M 753
2018
Q3
$1.11M Sell
8,671
-1,461
-14% -$181K 0.02% 337
2018
Q2
$1.15M Buy
10,132
+161
+2% +$17.7K 0.03% 312
2018
Q1
$1.12M Sell
9,971
-2,518
-20% -$320K 0.03% 328
2017
Q4
$1.85M Sell
12,489
-759
-6% -$96.5K 0.05% 198
2017
Q3
$1.55M Sell
13,248
-4,797
-27% -$613K 0.09% 248
2017
Q2
$2.34M Sell
18,045
-2,414
-12% -$301K 0.09% 238
2017
Q1
$2.77M Buy
20,459
+1,100
+6% +$167K 0.11% 211
2016
Q4
$2.78M Sell
19,359
-103
-0.5% -$13.2K 0.1% 218
2016
Q3
$2.3M Sell
19,462
-229
-1% -$27.5K 0.08% 268
2016
Q2
$2.08M Sell
19,691
-3,100
-14% -$346K 0.08% 292
2016
Q1
$2.54M Sell
22,791
-6,567
-22% -$831K 0.11% 200
2015
Q4
$4.6M Buy
29,358
+9,960
+51% +$1.45M 0.18% 104
2015
Q3
$2.55M Buy
19,398
+16
+0.1% +$2.57K 0.1% 221
2015
Q2
$3.37M Buy
19,382
+3,544
+22% +$638K 0.12% 167
2015
Q1
$2.73M Buy
15,838
+623
+4% +$95K 0.08% 289
2014
Q4
$1.97M Sell
15,215
-153
-1% -$19.7K 0.06% 570
2014
Q3
$1.98M Buy
15,368
+1,242
+9% +$128K 0.06% 465
2014
Q2
$1.25M Sell
14,126
-590
-4% -$56.7K 0.04% 803
2014
Q1
$1.38M Buy
14,716
+4,693
+47% +$480K 0.05% 748
2013
Q4
$1.13M Sell
10,023
-4,314
-30% -$389K 0.04% 741
2013
Q3
$1.13M Sell
14,337
-4,716
-25% -$345K 0.04% 534
2013
Q2
$1.25M Buy
+19,053
New +$1.23M 0.05% 478

Other funds holding UTHR

Liberty Mutual Group Asset Management's UTHR Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of United Therapeutics (UTHR) in Q4 2018, closing a stake of 8,671 shares — an estimated $1.11M sold.

Liberty Mutual Group Asset Management first reported a position in UTHR in Q2 2013 and held it in 22 quarters. The position peaked at $4.6M in Q4 2015. 360 funds tracked by Wall St. Rank hold UTHR as of Q4 2018.

  • Liberty Mutual Group Asset Management reported no remaining United Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 8,671 United Therapeutics shares in Q4 2018, an estimated $1.11M.
  • Liberty Mutual Group Asset Management first reported a position in United Therapeutics in Q2 2013 and held it in 22 quarters.
  • Liberty Mutual Group Asset Management's United Therapeutics position peaked at $4.6M in Q4 2015.
  • 360 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.